This article has been updated to include comments from PacBio management made during a conference call.

NEW YORK (GenomeWeb) – Pacific Biosciences reported after the close of the market Tuesday that its first quarter 2015 revenues climbed 52 percent.

The Menlo Park, California-based single-molecule sequencing technologies firm reported Q1 revenues of $17.6 million compared to $11.6 million in Q1 2014. It beat the consensus Wall Street estimate of $13.7 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers suggest that genetic variations could influence the side effects people experience when using synthetic cannabinoids, the International Business Times reports.

An analysis has examined the makeup of researchers on Twitter and what they share, Nature News reports.

At Stat News, Jim Kozubek argues that the Broad Institute is pushing the boundary of what a nonprofit is.

In PNAS this week: gut microbes may affect honeybee weight, phenotype and gene expression changes in DiGeorge syndrome, and more.